Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Simcere Pharmaceutical Group

http://en.simcere.com/

Latest From Simcere Pharmaceutical Group

Chinese Domestic Alliances Focus On China-Only Rights As Confidence Grows

Confidence in growing in-house commercial capabilities has recently prompted several Chinese pharmas, including Simcere and 3SBio, to focus on obtaining domestic rights to novel drug assets developed by other China-based biotechs, rather than pursuing international deals.

China Deals

China Drug Makers Brace As Anti-Graft Campaign Impact Surfaces

Simcere, Hengrui, and Zai Lab are among the first Chinese pharma firms to report various forms of impact from the gathering storm of a national anti-corruption campaign launched in July in the healthcare and pharma sectors.

China Compliance

Sosei Builds APAC Independence Through Idorsia Deal

Sosei Heptares' acquisition of Idorsia's ex-China APAC operations will give the Japan-UK group ready-made independent development and commercialization capabilities in Japan, accelerating by "five to 10 years" its goals in its home market, its CEO tells Scrip. The deal also brings a marketed drug and options to selected Idorsia pipeline assets. 

Japan Asia Pacific

Almirall Plots M&A Moves Ahead Of Lebrikizumab Approval

The Spanish group has been fairly quiet on the dealmaking front of late but the proceeds of a significant capital raise have been earmarked to help “swiftly execute inorganic growth opportunities.”

M & A Dermatology
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Jilin Boda Pharmaceutical Co., Ltd.
    • ChinaVax
    • Master Luck Corporation Limited
    • Jiangsu Simcere Pharmaceutical R&D Co., Ltd.
    • Jiangsu Yanshen Biological Technology Stock Co., Ltd.
    • Nanjing Tung Chit Pharmaceutical Co., Ltd.
    • Shandong Simcere Medgenn Bio-Pharmaceutical Co. Ltd.
    • Wuhu Zhong Ren Pharmaceutical Co. Ltd.
    • Xiangao Investment Company Ltd.
    • Yantai Medgenn Co. Ltd.
    • Jiangsu Simcere Pharmaceutical Co., Ltd.
UsernamePublicRestriction

Register